Document:

EXCLUSIVE
license agreement

     

    Between

     

    CLENERGEN
CORPORATION

     

    And

     

    BIOPOWER
CORPORATION

     

    November
30, 2010

    
      
         

      

      
        1

        
          

        

      

      
         

      

    

    LICENSE
AGREEMENT

     

    This
Agreement (the "Agreement"), dated November 30, 2010 (the Effective Date) is
entered into by and between Clenergen Corporation, a Nevada corporation and
public company (Licensor) and BioPower Corporation, a Florida corporation
(Licensee).

    

    WHEREAS,
Licensor produces high-density, short-rotation biomass crops on a
commercial scale using a proprietary integrated farming methodologies,
and

    

    WHEREAS, Licensor produces
power, steam, hydrogen, transport fuel, fertilizers, pesticides, chemicals and
other important products through advanced gasification and steam technologies,
and

    

    WHEREAS, Licensor has certain
rights to the use of various technologies and processes, and

    

    WHERAS, Licensee has been
established to, among other activities, collaborate with Licensor in developing
biomass projects and gasification and steam process projects in exclusive
territories, and

    

    WHEREAS, Licensor has agreed
to grant and Licensee has agreed to take, an exclusive license, for a territory,
to the rights relating to certain manufacturing, processing, marketing and the
sale of products produced through the use of Licensor’s proprietary processes on
the terms set out in this agreement.

    

    NOW, THEREFORE, Licensor and
Licensee agree as follows:

     

    Agreed
terms

     

    
      	
              1.

            	
              Interpretation

            

    

     

    
      	
              1.1

            	
              The
      definitions and rules of interpretation in this clause 1 apply in this
      agreement.

            

    

     

    Business Day: a day other than
a Saturday and a Sunday on which banks in the United States are open for
business.

    

    Field of Use: Production of (i)
high-density, short-rotation biomass crops on a commercial scale using a
proprietary integrated farming methodology and (ii) power, steam, hydrogen,
transport fuel, fertilizers, pesticides, chemicals and other important products
through advanced gasification;  steam technologies and any and all
other technologies.

     

    Improvement: any improvement, enhancement
or modification to the Licensed Technologies.

     

    License:  an
exclusive license for the defined territory.

     

    Licensed Technologies: the
technologies and processes owned by Clenergen, patented by Clenergen or in which
Clenergen may have license rights to, and have the right to sub license in the
Territory, and as may be described in Schedule 1, attached hereto and made a
part thereof.

     

    Quarterly Period:  the period of
three months commencing on 1 January, 1 April, 1 July and 1
October.

     

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

    Gross
Revenue:  defined as the total amount of revenue less the
direct costs paid for producing the revenue.

     

    Royalty Rate: an agreed percentage of the
annual Gross Revenue of BioPower.

     

    Exclusive Territory: United States, Central
America, Mexico, Guam and Cuba.

     

    
      	
              1.2

            	
              Clause
      headings shall not affect the interpretation of this
      agreement.

            

    

     

    
      	
              1.3

            	
              A
      person includes a
      corporate or unincorporated body (whether or not having separate legal
      personality).

            

    

     

    
      	
              1.4

            	
              Words
      in the singular shall include the plural and vice
  versa.

            

    

     

    
      	
              1.5

            	
              A
      reference to one gender shall include a reference to the other
      genders.

            

    

     

    
      	
              1.6

            	
              A
      reference to a law is a reference to it as it is in force for the time
      being, taking account of any amendment, extension, application or
      re-enactment and includes any subordinate legislation for the time being
      in force made under it.

            

    

     

    
      	
              1.7

            	
              Writing or written does not include
      fax or email.

            

    

     

    
      	
              2.

            	
              Grant
      of License

            

    

     

    
      	
              2.1

            	
              The
      Licensor hereby grants to the Licensee an exclusive license under the
      Field of Use, to use the Licensed Technologies in the Territory.
      Licensor agrees to allow Licensee the right to develop projects
      throughout South America, Haiti and the U.S. Virgin islands on a case by
      case basis and with written notice from the Licensee to the Licensor. The
      Licensee is prohibited from developing projects in the countries of Guyana
      and Suriname.

            

    

     

    
      	
              2.2

            	
              The
      Licensee shall have no right to grant sub-licences under this agreement
      unless it is to a subsidiary or joint venture company of the Licensee, and
      hereby undertakes not to purport to do
so.

            

    

     

    
      	
              2.3

            	
              The
      Licensor shall retain ownership of and the management of any brands
      relating to its business and shall allow the Licensee to use such brands
      provided that the Licensee complies with all instructions of the Licensor
      in respect of the use of the same.

            

    

     

    
      	
              2.4

            	
              No
      further right or licence is granted by the Licensor to the Licensee by
      this agreement, save as expressly set out in this clause
  2.

            

    

     

    
      	
              2.5

            	
              Provided
      that the Licensee retains an exclusive licence in respect of the Licensed
      Technologies, the Licensor undertakes, during the term of this agreement
      not to exploit the Licensed Technologies in the Territory in the Field of
      Use, or to purport to grant others the right to do
  so.

            

    

     

    
      	
              3.

            	
              Obligations
      of the Licensee

            

    

     

    
      	
              3.1

            	
              The
      Licensee shall comply with all requirements of the Licensor as to the use
      of any and all brand relating to the business of the
    Licensor.

            

    

     

    
      
         

      

      
        3

        
          

        

      

      
         

      

    

     

    
      	
              3.2

            	
              The
      Licensee shall use its best endeavours to promote and develop projects
      with the Licensor throughout the
Territory.

            

    

     

    
      	
              4.

            	
              Further
      Licences

            

    

     

    The
Licensor agrees to include any and all additional technologies and
processes that it may develop or gain access to in the future and that may
enhance the business of the Licensee relative to the Field of Use in the
Territory.  Any such technologies and processes shall be included,
from time to time and when relevant, in this Agreement on the attached Schedule
One and will be attached hereto and made a part
thereof.  

     

    
      	
              5.

            	
              Provision
      of know-how

            

    

     

    
      	
              5.1

            	
              The
      Licensor shall make available to the Licensee such know-how relating to
      the Licensed Technologies as the Licensor may reasonably consider being
      necessary for the purposes of the Licensee properly developing and
      managing projects in the Territory.

            

    

     

    
      	
              5.2

            	
              The
      know-how supplied by the Licensor under clause 5.1 shall be used by the
      Licensee only for the purpose of the development of projects in the
      Territory, in the Field of Use and shall be subject to the provisions of
      Clause 8.

            

    

     

    
      	
              6.

            	
              Improvement

            

    

     

    
      	
              6.1

            	
              If
      the Licensee at any time develops any Improvement or gains access to any
      new technology or process to enhance the Field of Use it shall, to the
      extent that it is not prohibited by law or by any obligation to any other
      person, promptly notify the Licensor in writing, giving details of the
      Improvement or new technology or process and shall provide to the Licensor
      such information as it shall reasonably require to be able effectively to
      evaluate the Improvement or new technology or process. Should the Licensor
      then so request, the Licensee shall grant to the Licensor a non-exclusive
      irrevocable world-wide license without limit of time with the right to
      assign and to grant sub-licenses thereunder in respect of that Improvement
      or new technology or processes.

            

    

     

    
      	
              7.

            	
              Confidentiality
      and indemnification

            

    

     

    
      	
              7.1

            	
              The
      Licensee undertakes that it shall keep (and it shall procure that its
      respective directors and employees keep) secret and confidential all
      know-how relating to the Licensed Technologies and any information
      (whether or not technical) of a confidential nature to the Licensor
      communicated to it by the Licensor, either preparatory to, or as a result
      of, this agreement, and shall not disclose the same or any part of the
      same to any person other than its directors or employees directly or
      indirectly concerned in the development of projects, provided that, before
      any such disclosure takes place, the Licensee shall procure that each of
      the directors and employees concerned shall execute a confidentiality
      undertaking with the Licensor in a form approved by the Licensor, such
      approval not to be unreasonably
withheld.

            

    

     

    
      	
              7.2

            	
              The
      provisions of clause 7.1 shall not apply to such know-how and information
      as the Licensee:

            

    

     

    
      	
               
      

            	
              (a)

            	
              can
      prove to have been in its possession at the date of receipt, or which
      becomes public knowledge otherwise than through a breach of an obligation
      of confidentiality owed (whether directly or indirectly) to the Licensor;
      or

            

    

     

    
      
         

      

      
        4

        
          

        

      

      
         

      

    

    
      	
               
      

            	
              (b)

            	
              is
      necessarily disclosed as a result of the marketing of, developing or
      management of any project.

            

    

     

    
      	
              7.3

            	
              The
      Licensee shall, at the request of the Licensor but at the expense of the
      Licensee, take such steps as the Licensor may require to enforce any
      confidentiality undertaking given by a director or employee of the
      Licensee including, in particular but without limitation, the initiation
      and prosecution of any legal proceedings and the enforcement of any
      judgment obtained. All such steps to be taken by the Licensee shall be
      taken as expeditiously as possible and the Licensee agrees that, in
      respect of its obligation to enforce confidentiality undertakings, time
      shall be of the essence in complying with the requirements of the
      Licensor.

            

    

     

    
      	
              7.4

            	
              The
      provisions of this clause 7 shall remain in force notwithstanding expiry
      or earlier termination of this
agreement.

            

    

     

    
      	
              7.5

            	
              LICENSOR
      shall indemnify, defend and hold LICENSEE harmless from and against any
      and all Losses resulting from or arising out of the negligence or wilful
      misconduct of LICENSOR in the performance of its obligations under this
      Agreement.  Without limiting the generality of the foregoing,
      LICENSOR shall indemnify, defend and hold LICENSEE harmless from and
      against any losses relating to product liability claims solely with
      respect to LICENSOR Products which may be purchased, designed, developed
      and manufactured solely and independently by
  LICENSOR.

            

    

     

    
      	
              7.6

            	
              LICENSEE
      shall indemnify, defend and hold LICENSOR harmless from and against any
      losses resulting from or arising out of the negligence of willful
      misconduct of LICENSEE in performing its obligations under this Agreement.
      Without limiting the generality of the foregoing, LICENSEE shall
      indemnify, defend and hold LICENSOR harmless from and against any losses
      resulting from any defect or deficiency with respect to any LICENSEE
      contribution which is the subject of the cooperative efforts pursuant to
      this Agreement.

            

    

     

    
      	
              7.7

            	
              A
      Party seeking indemnification (the "Indemnified Party") pursuant to this
      Section shall notify, in writing, the other Party (the "Indemnifying
      Party") within fifteen (15) days of the assertion of any claim or
      discovery of any fact upon which the Indemnified Party intends to base a
      claim for indemnification. An Indemnified Party's failure to so notify the
      Indemnifying Party shall not, however, relieve the Indemnifying Party from
      any liability under this Agreement to the Indemnified Party with respect
      to such claim except to the extent that such Indemnifying Party is
      actually denied, during the period of delay in notice, or materially
      prejudiced with respect to, the opportunity to remedy or otherwise
      mitigate the event or activity(ies) giving rise to the claim
      for  indemnification and thereby  suffers or otherwise
      incurs  additional  quantifiable  damages  as
      a  result  of  such  failure.  The
      Indemnifying Party, while reserving the right to contest its obligations
      to indemnify hereunder, shall be responsible for the defense of any claim,
      demand, lawsuit or other proceeding in connection with which the
      Indemnified Party claims indemnification hereunder. The Indemnified Party
      shall have the right at its own expense to participate jointly with the
      Indemnifying Party in the defense of any such claim, demand, lawsuit or
      other proceeding, but with respect to any issue involved in such claim,
      demand, lawsuit or other proceeding with respect to which the Indemnifying
      Party has acknowledged its obligation to indemnify the Indemnified Party
      hereunder, the Indemnifying Party shall have the right to select counsel,
      settle, try or otherwise dispose of or handle  such
      claim,  demand,  lawsuit or
      other  proceeding  on such terms as the Indemnifying
      Party shall deem appropriate, subject to any reasonable objection of the
      Indemnified Party.

            

    

     

    
      
         

      

      
        5

        
          

        

      

      
         

      

    

     

    
      	
              8.

            	
              Royalty

            

    

     

    
      	
              8.1

            	
              In
      consideration of the rights granted under clause 2, the Licensee shall pay
      to the Licensor royalties, on each twelve month time period, first
      calculated from the date of execution of this Agreement, and calculated on
      a scale as follows:

            

    

     

    
      	
               
      

            	
              (a)

            	
              8%
      of the first $50,000,000.00 of Gross Revenue, or any part
      thereof,

            

    

     

    
      	
               
      

            	
              (b)

            	
              3%
      of the second $50,000,000.00 of Gross Revenue, or any part
      thereof

            

    

     

    
      	
               
      

            	
              (c)

            	
              1%
      of any and all Gross Revenue over
  $100,000,000.00.

            

    

     

    
      8% will
be the licensee fee on the first $50,000,000.00 of Gross Revenue providing that
Clenergen never charges anyone else a lesser percentage, and if so, then the 8%
will revert to the lowest of any percentage Clenergen charges for a license
fee.

       

    

    
      	
              8.2

            	
              Royalties
      payable under this agreement shall be paid in US Dollars within 30
      days of the end of each successive Quarterly
  Period.

            

    

     

    
      	
              8.3

            	
              At
      the same time as payment of royalties falls due, the Licensee shall submit
      or cause to be submitted to the Licensor a statement in writing recording
      the calculation of such royalties payable and
  due.

            

    

     

    
      	
              8.4

            	
              The
      Licensee shall keep proper records and books of account and be open at all
      times to inspection and audit by the Licensor (or its duly authorised
      agent or representative), who shall be entitled to take copies of or
      extracts from the same. If such inspection or audit should reveal a
      discrepancy in the royalties paid from those payable under this agreement,
      the Licensee shall immediately make up the shortfall and reimburse the
      Licensor in respect of any professional charges incurred for such audit or
      inspection.

            

    

     

    
      	
              8.5

            	
              The
      provisions of this clause 8 shall remain in effect notwithstanding
      termination or expiry of this agreement until the settlement of all
      subsisting claims by the Licensor.

            

    

     

    
      	
              9.

            	
              Protection
      of the Licensed Technologies

            

    

     

    
      	
              9.1

            	
              In
      the event that:

            

    

     

    
      	
               
      

            	
              (a)

            	
              any
      Licensed Technology is attacked or opposed;
or

            

    

     

    
      	
               
      

            	
              (b)

            	
              any
      application for a patent is made by or any patent is granted to a third
      party by reason of which the third party may be granted, or may have been
      granted, rights which conflict with any of the rights granted to the
      Licensee under any Licensed Technology;
or

            

    

     

    
      	
               
      

            	
              (c)

            	
              any
      unlicensed activities are carried on by any third party which could
      constitute an infringement of any Licensed Technology;
  or

            

    

     

    
      	
               
      

            	
              (d)

            	
              any
      application is made for a compulsory licence under any Licensed
      Technology,

            

    

     

    the party
becoming aware of such a matter shall immediately notify the other of it and
upon the request of one party the other shall join it in taking all such steps
(if any) as may be desirable for the protection of the rights of the Licensor
under the Licensed Technologies. The expenses incurred in taking such steps and
any profits or damages which may be obtained shall be (in the absence of
agreement to the contrary) for the account of the Licensor.

     

    
      
         

      

      
        6

        
          

        

      

      
         

      

    

     

    
      	
              10.

            	
              Duration
      and termination

            

    

     

    
      	
              10.1

            	
              This
      agreement shall come into force on the date on which it is signed by both
      parties and shall, unless determined in accordance with clause 12.2,
      remain in force.

            

    

     

    
      	
              10.2

            	
              The
      Licensor shall have the right to terminate this agreement immediately by
      notice in writing to the Licensee in the event
  that:

            

    

     

    
      	
               
      

            	
              (a)

            	
              the
      Licensee fails to perform or observe any of its obligations under this
      agreement, provided that, in a case where the Licensor considers the
      breach to be remediable, such notice from the Licensor shall also require
      the Licensee to remedy such breach and if the Licensee so remedies within
      90 days of such notice being served, such notice to terminate this
      agreement shall be deemed to be void and of no effect;
  or

            

    

     

    
      	
               
      

            	
              (b)

            	
              an
      interim order is applied for or made, or a voluntary arrangement approved,
      or a petition for a bankruptcy order is presented or a bankruptcy order is
      made against the Licensee, or a receiver or trustee in bankruptcy is
      appointed of the estate of the Licensee or a voluntary arrangement is
      proposed or approved or an administration order is made, or a receiver or
      administrative receiver is appointed of any of the assets or undertaking
      of the Licensee , or a winding-up resolution or petition is passed or
      presented (otherwise than for the purposes of solvent reconstruction or
      amalgamation) or any circumstances arise which entitle the court or a
      creditor or the company or its directors to appoint a receiver,
      administrative receiver or administrator or to present a winding-up
      petition or make a winding-up order, or other similar or equivalent action
      is taken against or by the Licensee by reason of its insolvency or in
      consequence of debt;

            

    

     

    
      	
               
      

            	
              (c)

            	
              the
      Licensee challenges the validity of any of the Licensed
      Technologies;

            

    

     

    
      	
              10.3

            	
              In
      the event of expiry or termination of this agreement howsoever arising,
      and subject to any express provisions set out elsewhere in this
      agreement:

            

    

     

    
      	
               
      

            	
              (a)

            	
              all
      outstanding sums payable by the Licensee to the Licensor shall immediately
      become due and payable;

            

    

     

    
      	
               
      

            	
              (b)

            	
              all
      rights and licences granted pursuant to this agreement shall
      cease;

            

    

     

    
      	
               
      

            	
              (c)

            	
              the
      Licensee shall cease all and any exploitation of the Licensed Technologies
      and of any know-how provided by the Licensor to the Licensee, except
      insofar as such know-how ceases or has ceased to be confidential, unless
      this is or was as a consequence of the default of the
      Licensee;

            

    

     

    
      	
               
      

            	
              (d)

            	
              the
      Licensee shall co-operate with the Licensor in the cancellation of all or
      any licences registered pursuant to this agreement and shall execute such
      documents and do all acts and things as may be necessary to effect such
      cancellation;

            

    

     

    
      	
               
      

            	
              (e)

            	
              the
      Licensee shall return promptly to the Licensor all technical and
      promotional material in its possession relating to the Product and the
      know-how, and all copies of such material to the extent such material
      remains confidential; and

            

    

     

    
      
         

      

      
        7

        
          

        

      

      
         

      

    

     

    
      	
              10.4

            	
              The
      expiry or termination of this agreement for any reason shall be without
      prejudice to the provisions of this clause 12 and to any rights of either
      party which may have accrued by, at or up to the date of such
      termination.

            

    

     

    
      	
              11.

            	
              Assignment
      and transfer of Licensed
Technologies

            

    

     

    
      	
              11.1

            	
              The
      Licensee shall not assign, transfer, mortgage, charge, encumber or
      otherwise deal in any other manner with this agreement or any of its
      rights and obligations under this agreement, or purport to do any of the
      same.

            

    

     

    
      	
              11.2

            	
              Should
      the Licensor seek to transfer its ownership of the Licensed Technologies
      to any other person then it shall serve written notice on the Licensee
      advising it of:

            

    

     

    
      	
               
      

            	
              (a)

            	
              the
      fact that it wishes to transfer the Licensed Technologies and to whom;
      and

            

    

     

    
      	
               
      

            	
              (b)

            	
              the
      terms by which it intends to transfer the Licensed
      Technologies,

            

    

     

    and the
Licensee shall have the first option to acquire the ownership of the Licensed
Technologies on terms no less favorable than those being offered to the other
party to whom the Licensor wishes to transfer the Licensed
Patents.  .

     

    
      	
              12.

            	
              Unenforceability

            

    

     

    
      	
              12.1

            	
              If
      any provision of this agreement (or part of any provision) is found by any
      court or other body of competent jurisdiction to be invalid, unenforceable
      or illegal, the other provisions shall remain in
  force.

            

    

     

    
      	
              12.2

            	
              If
      any invalid, unenforceable or illegal provision would be valid,
      enforceable and legal if some part of it were deleted, the provision shall
      apply with whatever modification is necessary to give effect to the
      commercial intention of the
parties.

            

    

     

    
      	
              13.

            	
              Waiver

            

    

     

    No
failure or delay by a party to exercise any right or remedy provided under this
agreement or by law shall constitute a waiver of that (or any other) right or
remedy. No single or partial exercise of such right or remedy shall preclude or
restrict the further exercise of that (or any other) right or
remedy.

     

    
      	
              14.

            	
              Variation

            

    

     

    No
variation or agreed termination of this agreement or of any document referred to
in it shall be effective unless it is in writing and signed by or on behalf of
each of the parties.

     

    
      	
              15.

            	
              Further
      assurance

            

    

     

    The
parties shall (at their own expense) use all reasonable endeavors to procure
that any necessary third party shall execute such documents and perform such
acts as may reasonably be required for the purpose of giving full effect to this
agreement.

     

    
      
         

      

      
        8

        
          

        

      

      
         

      

    

     

    
      	
              16.

            	
              Entire
      agreement

            

    

     

    
      	
              16.1

            	
              This
      agreement (and any document referred to in it) constitutes the whole
      agreement between the parties and supersedes all previous agreements
      between the parties relating to its subject
  matter.

            

    

     

    
      	
              16.2

            	
              Each
      party acknowledges that, in entering into this agreement (and any document
      referred to in it), it has not relied on, and shall have no right or
      remedy in respect of, any statement, representation, assurance or warranty
      (whether made negligently or innocently) other than as expressly set out
      in this agreement.

            

    

     

    
      	
              16.3

            	
              Nothing
      in this clause 18 shall limit or exclude any liability for
      fraud.

            

    

     

    
      
        	
                17.

              	
                Notice

              
	 	 

      

    

    
      	
              17.1

            	
              Any
      notice required to be given hereunder by either party to the other shall
      be in writing and shall be served by sending the same by registered or
      recorded delivery post or facsimile to the registered office of the other
      party or to such other address as that party may have previously notified
      to the other as being the address for such service. Any notice sent by
      mail shall be deemed (in the absence of evidence of earlier receipt) to
      have been delivered 5 days after being mailed and, in proving the fact of
      mailing, it shall be sufficient to show that the envelope containing such
      notice was properly addressed, stamped and posted. Any notice sent by fax
      shall be deemed to have been delivered on the day following its
      despatch.

            

    

     

    
      Clenergen
Corporation

    

    5379
Lyons Road

    Suite
301

    Coconut
Creek, FL 33073 USA

    Attn:
Mark LM Quinn, Chairman

    

    
      BioPower
Corporation

    

    5379
Lyons Road

    Suite
301

    Coconut
Creek, FL 33073 USA

    
      Attn:
Robert D. Kohn, CEO

    

    

    
      A notice
or other communication required to be given under this agreement shall not be
validly given if sent by e-mail.

    

     

    
      	
              17.2

            	
              The
      provisions of this clause 19 shall not apply to the service of any
      proceedings or other documents in any legal
  action.

            

    

     

    
      	
              18.

            	
              Rights
      of third parties

            

    

     

    A person
who is not a party to this agreement shall not have any rights under or in
connection with it.

     

    
      	
              19.

            	
              Governing
      law and jurisdiction

            

    

     

    
      	
              19.1

            	
              This
      agreement and any dispute or claim arising out of or in connection with it
      or its subject matter or formation (including non-contractual disputes or
      claims) shall be governed by and construed in accordance with the laws of
      the State of Florida.

            

    

     

    
      
         

      

      
        9

        
          

        

      

      
         

      

    

     

    
      	
              19.2

            	
              The
      parties irrevocably agree that the courts of the State of Florida shall
      have exclusive jurisdiction to settle any dispute or claim that arises out
      of or in connection with this agreement or its subject matter or formation
      (including non-contractual disputes or
claims).

            

    

     

    This
agreement has been entered into on the date stated at the beginning of this
agreement.

    

    IN WITNESS WHEREOF, the parties hereto
have executed and delivered this agreement as a deed the day and year first
before written.

    

    
      
        
          
            	
                    CLENERGEN
      CORPORATION

                  
	 
      	 
      	 
      
	 
      	 
      	
                    Dated:   11-30-2010

                  
	
                    Mark
      LM Quinn, CEO

                  	 
      	 
      
	 
      	 
      	 
      
	
                    BIOPOWER
      CORPORATION

                  
	 
      	 
      	 
      
	 
      	 
      	
                    Dated:   11-30-2010

                  
	
                    Robert
      D. Kohn, CEO

                  	 
      	 
      

          

        

      

    

     

    
      
         

      

      
        10SUBSCRIPTION
AGREEMENT FOR THE PURCHASE OF SHARES

       

      BioPower Operations
Corporation, a Nevada corporation (the “Company”), is offering (this
“Offering”) for sale to
“accredited investors”
as the term is defined under Regulation D promulgated under the Securities Act
of 1933, as amended (the “Act”), Shares for a purchase
price of $0.50 per Share, of the Company’s common stock, par value $0.0001 per
share (“Common
Stock”).

       

      Subscription
Procedures

       

      (a)          The
undersigned hereby subscribes to purchase ________________ shares of Common
Stock and agrees to pay an aggregate of $______________ as the subscription
amount for the securities being purchased hereunder (the “Subscription
Amount”).

       

      (b)          To
subscribe, the undersigned must:

       

      
        	
                 
      

              	
                (i)

              	
                complete
      and sign this Subscription Agreement;
and

              

      

       

      
        	
                 
      

              	
                (ii)

              	
                complete
      and sign the accompanying Confidential Prospective Purchaser Questionnare
      (Subscription Agreement, together with the Confidential Prospective
      Purchaser Questionnare collectively referred to as the “Subscription
      Documents”);

              

      

       

      
        	
                 
      

              	
                (iii)

              	
                return
      the completed and signed Subscription Documents on behalf of the Company
      at the following address:

              

      

       

      BioPower
Operations Corporation

      5379
Lyons Road, Suite 301

      Coconut
Creek, FL 33073

      Attn:
Robert Kohn

       

      (iv)         Deliver
a check payable to “BioPower Operations Corporation” for an amount equal to the
aggregate amount of Common Stock subscribed for in this offering and send to
5379 Lyons Rd., Suite 301, Coconut Creek, Florida 33073. The undersigned may
wire the Subscription Amount to the Company upon request to the
Company.

       

      (c)          The
Offering is scheduled to terminate on __________, 2011, 5:00 p.m., New York
time, unless extended by the Company for an additional [90] days, in the sole
discretion of the Company  (the “Offering
Period”).

       

      (d)          The
Company will hold a closing on and issue the Common Stock upon the receipt and
acceptance of the Subscription Documents and the Subcription Amount (each a
“Closing”). The date of
each such Closing is referred to herein as the Closing Date.

       

      
        
           

        

        
           

          
            

          

        

        
           

        

      

       

      (e)           All
subscription proceeds will be deposited into the Company’s bank account as
provided herein.  Upon each Closing, the funds, subject to the payment
of the expenses and fees incurred in connection with this Offering, will be
immediately available to the Company.  In the event that an investor’s
subscription is rejected by the Company, or this Offering is terminated for any
reason without a closing, subscription proceeds will be promptly refunded
without interest thereon or deduction therefrom.

       

      Prospective
Investors should retain their own professional advisors to review and evaluate
the economic, tax, and other consequences of an investment in the
Company.

       

      THE
SECURITIES OFFERED HEREBY, HAVE NOT BEEN FILED OR REGISTERED WITH OR APPROVED BY
THE SECURITIES AND EXCHANGE COMMISSION (THE “COMMISSION”), NOR HAS THE
COMMISSION PASSED UPON THE ACCURACY OR ADEQUACY OF THE OFFERING MATERIALS. NO
STATE SECURITIES LAW ADMINISTRATOR HAS PASSED ON OR ENDORSED THE MERITS OF THIS
OFFERING OR THE ACCURACY OR THE ADEQUACY OF THE OFFERING MATERIALS. ANY
REPRESENTATION TO THE CONTRARY IS UNLAWFUL.

       

      IT
IS INTENDED THAT THE SECURITIES OFFERED HEREBY WILL BE MADE AVAILABLE TO
ACCREDITED INVESTORS, AS DEFINED IN REGULATION D AND RULE 501 PROMULGATED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE “1933 ACT”) AND UP TO THIRTY-FIVE
NON-ACCREDITED INVESTORS.  THE SECURITIES OFFERED HEREBY ARE BEING
OFFERED PURSUANT TO AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE 1933
ACT AND APPLICABLE STATE SECURITIES LAWS FOR NONPUBLIC OFFERINGS. SUCH
EXEMPTIONS LIMIT THE NUMBER AND TYPES OF INVESTORS TO WHICH THE OFFERING WILL BE
MADE AND RESTRICT SUBSEQUENT TRANSFERS OF THE INTERESTS.

       

      THE
SECURITIES OFFERED HEREBY SHOULD BE CONSIDERED ONLY BY PERSONS WHO CAN AFFORD TO
SUSTAIN A LOSS OF THEIR ENTIRE INVESTMENT. INVESTORS WILL BE REQUIRED TO
REPRESENT THAT THEY ARE FAMILIAR WITH AND UNDERSTAND THE TERMS OF THIS
OFFERING.

       

      NO
SECURITIES MAY BE RESOLD OR OTHERWISE DISPOSED OF BY AN INVESTOR UNLESS, IN THE
OPINION OF COUNSEL SATISFACTORY TO THE COMPANY, REGISTRATION UNDER THE
APPLICABLE FEDERAL OR STATE SECURITIES LAWS IS NOT REQUIRED OR COMPLIANCE IS
MADE WITH SUCH REGISTRATION REQUIREMENTS.

       

      THE
OFFEREE, BY ACCEPTING DELIVERY OF THE OFFERING MATERIALS, AGREES TO RETURN THE
OFFERING MATERIALS AND ALL ACCOMPANYING OR RELATED DOCUMENTS TO THE COMPANY UPON
REQUEST IF THE OFFEREE DOES NOT AGREE TO PURCHASE ANY OF THE SECURITIES OFFERED
HEREBY.

       

      
        
           

        

        
          - 2
-

          
            

          

        

        
           

        

      

       

      ANY
OFFERING MATERIALS SUBMITTED IN CONNECTION WITH THE PRIVATE PLACEMENT OF THE
SECURITIES DO NOT CONSTITUTE AN OFFER OR SOLICITATION BY ANYONE IN ANY
JURISDICTION IN WHICH SUCH AN OFFER OR SOLICITATION IS NOT
AUTHORIZED.  ANY REPRODUCTION OR DISTRIBUTION OF ANY OFFERING
MATERIALS IN WHOLE OR IN PART, OR THE DIVULGENCE OF ANY OF THEIR CONTENTS,
WITHOUT THE PRIOR WRITTEN CONSENT OF THE COMPANY, IS PROHIBITED. ANY PERSON
ACTING CONTRARY TO THE FOREGOING RESTRICTIONS MAY PLACE HIM/HERSELF AND THE
COMPANY IN VIOLATION OF FEDERAL OR STATE SECURITIES LAWS.

       

      
        
           

        

        
          - 3
-

          
            

          

        

        
           

        

      

      NASAA
UNIFORM LEGEND

       

      IN
MAKING AN INVESTMENT DECISION INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF
THE COMPANY AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS
INVOLVED. THESE SECURITIES HAVE NOT BEEN RECOMMENDED BY ANY FEDERAL OR STATE
SECURITIES COMMISSION OR REGULATORY AUTHORITY. FURTHERMORE, THE FOREGOING
AUTHORITIES HAVE NOT CONFIRMED THE ACCURACY OR DETERMINED THE ADEQUACY OF THIS
DOCUMENT. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE. THESE
SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT
BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE 1933 ACT, AND THE
APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION
THEREFROM. INVESTORS SHOULD BE AWARE THAT THEY WILL BE REQUIRED TO BEAR THE
FINANCIAL RISKS OF THIS INVESTMENT FOR AN INDEFINITE PERIOD OF
TIME.

       

      The
undersigned acknowledges that the Common Stock offered hereby will not be
registered under the 1933 Act, or the securities laws of any State, that absent
an exemption from registration contained in those laws, the issuance and sale of
such Common Stock, as applicable, would require registration, and that the
Company's reliance upon such exemption is based upon the undersigned's
representations, warranties, and agreements contained in the Offering Materials
(as defined below).

       

      1.         
  The undersigned represents, warrants, and agrees as
follows:

       

      (a)          The
undersigned agrees that this Subscription Agreement is and shall be
irrevocable.

       

      (b)        
 The undersigned has carefully read this Subscription Agreement, the
Confidential Term Sheet and the Confidential Prospective Purchaser Questionnaire
(collectively the “Offering
Materials”), all of which the undersigned acknowledges have been provided
to the undersigned.  The undersigned has been given the opportunity to
ask questions of, and receive answers from the Company concerning the terms and
conditions of this Offering and the Offering Materials and to obtain such
additional written information, to the extent the Company possesses such
information or can acquire it without unreasonable effort or expense, necessary
to verify the accuracy of the same as the undersigned desires in order to
evaluate the investment.  The undersigned further acknowledges that
the undersigned fully understands the Offering Materials, and the undersigned
has had the opportunity to discuss any questions regarding any of the Offering
Materials with the undersigned’s counsel or other
advisor.  Notwithstanding the foregoing, the only information upon
which the undersigned has relied is that set forth in the Offering Materials and
the undersigned’s own independent investigation.  The undersigned
acknowledges that the undersigned has received no representations or warranties
from the Company or its employees, director, or agents in making this investment
decision other than as set forth in the Offering Materials.

       

      
        
           

        

        
          - 4
-

          
            

          

        

        
           

        

      

        

      (c)          The
undersigned is aware that the purchase of the Common Stock is a speculative
investment involving a high degree of risk and that there is no guarantee that
the undersigned will realize any gain from this investment, and that the
undersigned could lose the total amount of the undersigned's
investment.

       

      (d)          The
undersigned understands that no federal or state agency has made any finding or
determination regarding the fairness of this Offering of the Common Stock for
investment, or any recommendation or endorsement of this Offering of the Common
Stock.

       

      (e)          The
Undersigned is an “accredited investor” as that term is defined in Rule 501(a)
of Regulation D under the 1933 Act. The Undersigned has such knowledge and
experience in financial and business matters that it is capable of evaluating
the merits and risks of the purchase of the Common Stock.  The
Undersigned is not registered as a broker or dealer under Section 15(a) of the
1934 Act, affiliated with any broker or dealer registered under Section 15(a) of
the Securities Exchange Act of 1934, as amended, or a member of the Financial
Industry Regulatory Authority.

       

      (f)           Each
of this Agreement and the Offering Materials have been duly and validly
authorized, executed and delivered on behalf of the Undersigned and is a valid
and binding agreement of the Undersigned enforceable against the Undersigned in
accordance with their terms, subject as to enforceability to general principles
of equity and to applicable bankruptcy, insolvency, reorganization, moratorium,
liquidation and other similar laws relating to, or affecting generally, the
enforcement of applicable creditors’ rights and remedies.  The
Undersigned has the requisite corporate power and authority to enter into and
perform its obligations under this Agreement and the Offering Materials and each
other agreement entered into by the parties hereto in connection with the
transactions contemplated by this Agreement.

       

      (g)          The
execution, delivery and performance of this Agreement and the Offering Materials
by the Undersigned and the consummation by the Undersigned of the transactions
contemplated hereby and thereby will not (i) result in a violation of the
certificate of incorporation, by-laws or other documents of organization of the
Undersigned, (ii) conflict with, or constitute a default (or an event which with
notice or lapse of time or both would become a default) under, or give others
any rights of termination, amendment, acceleration or cancellation of, any
agreement, indenture or instrument to which the Undersigned is bound, or (iii)
result in a violation of any law, rule, regulation or decree applicable to the
Undersigned.

       

      (h)          The
Undersigned understands that there is a limited public trading market for the
Common Stock, and the Common Stock must be held indefinitely unless and until
such Common Stock is registered under the 1933 Act or an exemption from
registration is available.  The Undersigned has been advised or is
aware of the provisions of Rule 144 promulgated under the 1933 Act.

      

      (i)          
The Undersigned understands that the Common Stock is being offered and sold in
reliance on a transactional exemption from the registration requirements of
Federal and state securities laws and that the Company is relying upon the truth
and accuracy of the representations, warranties, agreements, acknowledgments and
understandings of the Undersigned set forth herein in order to determine the
applicability of such exemptions and the suitability of the Undersigned to
acquire the Common Stock.
 

      
        
           

        

        
          - 5
-

          
            

          

        

        
           

        

      

       

      (j)           The
undersigned is purchasing the Common Stock for the undersigned's own account,
with the intention of holding the Common Stock, with no present intention of
dividing or allowing others to participate in this investment or of reselling or
otherwise participating, directly or indirectly, in a distribution of the Common
Stock, and shall not make any sale, transfer, or pledge thereof without
registration under the Act and any applicable securities laws of any state or
unless an exemption from registration is available under those
laws.

       

      (k)           The
undersigned represents that the undersigned, if an individual, has adequate
means of providing for his or her current needs and personal and family
contingencies and has no need for liquidity in this investment in the Common
Stock.  The undersigned has no reason to anticipate any material
change in his or her personal financial condition for the foreseeable
future.

       

      (l)           The
undersigned is financially able to bear the economic risk of this investment,
including the ability to hold the Common Stock indefinitely or to afford a
complete loss of the undersigned’s investment in the Common Stock.

       

      (m)          The
undersigned represents that the undersigned's overall commitment to this
investment is not disproportionate to the undersigned's net worth, and the
undersigned's investment in the Common Stock will not cause such overall
commitment to become excessive.  The undersigned understands that the
statutory basis on which the Common Stock is being sold to the undersigned and
others would not be available if the undersigned's present intention were to
hold the Common Stock for a fixed period or until the occurrence of a certain
event.  The undersigned realizes that in the view of the Commission, a
purchase now with a present intent to resell by reason of a foreseeable specific
contingency or any anticipated change in the market value, or in the condition
of the Company, or that of the industry in which the business of the Company is
engaged or in connection with a contemplated liquidation, or settlement of any
loan obtained by the undersigned for the acquisition of the Common Stock, and
for which such Common Stock may be pledged as security or as donations to
religious or charitable institutions for the purpose of securing a deduction on
an income tax return, would, in fact, represent a purchase with an intent
inconsistent with the undersigned's representations to the Company and the
Commission would then regard such sale as a sale for which the exemption from
registration is not available.  The undersigned will not pledge,
transfer, or assign this Subscription Agreement.

       

      (m)          The
undersigned represents that the funds provided for this investment are either
separate property of the undersigned, community property over which the
undersigned has the right of control, or are otherwise funds as to which the
undersigned has the sole right of management.

       

      
        
           

        

        
          - 6
-

          
            

          

        

        
           

        

      

      (n)          FOR PARTNERSHIPS, CORPORATIONS,
TRUSTS, OR OTHER ENTITIES ONLY:  If the undersigned is a
partnership, corporation, trust, or other entity, (i) the undersigned has
enclosed with this Subscription Agreement appropriate evidence of the authority
of the individual executing this Subscription Agreement to act on its behalf
(e.g., if a trust, a certified copy of the trust agreement; if a corporation, a
certified corporate resolution authorizing the signature and a certified copy of
the articles of incorporation; or if a partnership, a certified copy of the
partnership agreement), (ii) the undersigned represents and warrants that it was
not organized or reorganized for the specific purpose of acquiring the Common
Stock, (iii) the undersigned has the full power and authority to execute this
Subscription Agreement on behalf of such entity and to make the representations
and warranties made herein on its behalf, and (iv) this investment in the
Company has been affirmatively authorized, if required, by the governing board
of such entity and is not prohibited by the governing documents of the
entity.

       

      (o)          The
address shown under the undersigned's signature at the end of this Subscription
Agreement is the undersigned's principal residence if he or she is an
individual, or its principal business address if a corporation or other
entity.

       

      (p)          The
undersigned has such knowledge and experience in financial and business matters
as to be capable of evaluating the merits and risks of an investment in the
Common Stock.

       

      (q)          The
undersigned acknowledges that the certificates for the securities comprising the
Common Stock which the undersigned will receive will contain a legend
substantially as follows:

       

      “THE
SECURITIES WHICH ARE REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, TRANSFERRED,
HYPOTHECATED OR OTHERWISE DISPOSED OF UNTIL A REGISTRATION STATEMENT WITH
RESPECT THERETO IS DECLARED EFFECTIVE UNDER SUCH ACT, OR THE COMPANY RECEIVES AN
OPINION OF COUNSEL FOR THE COMPANY THAT AN EXEMPTION FROM THE REGISTRATION
REQUIREMENTS OF SUCH ACT IS AVAILABLE.”

       

      The undersigned further acknowledges
that (i) if the Company’s Common Stock becomes publicly traded, any necessary
stop transfer orders will be placed upon the Company’s Common Stock, as
applicable, in accordance with the Act, and (ii) the Company is under no
obligation to aid the undersigned in obtaining any exemption from the
registration requirements.

       

      2.            The
undersigned expressly acknowledges and agrees that the Company is relying upon
the undersigned's representations contained in the Offering
Materials.

       

      3.           
The undersigned subscriber acknowledges that the undersigned understands the
meaning and legal consequences of the representations and warranties which are
contained herein and hereby agrees to indemnify, save and hold harmless the
Company and its officers, directors and counsel, from and against any and all
claims or actions arising out of a breach of any representation, warranty or
acknowledgment of the undersigned contained in any of the Offering
Materials.  Such indemnification shall be deemed to include not only
the specific liabilities or obligations with respect to which such indemnity is
provided, but also all reasonable costs, expenses, counsel fees and expenses of
settlement relating thereto, whether or not any such liability or obligation
shall have been reduced to judgment.  In addition, the undersigned's
representations, warranties, and indemnification contained herein shall survive
the undersigned's purchase of the Common Stock hereunder.  The
undersigned specifically acknowledges that he has reviewed the risks set forth
in the Offering Materials, as well as the financial statements included
therein.

       

      
        
           

        

        
          - 7
-

          
            

          

        

        
           

        

      

       

      4.           The
Company represents that it has been duly and validly incorporated and is validly
existing and in good standing as a corporation under the laws of the State of
Nevada. The Company represents that it has all requisite power and authority,
and all necessary authorizations, approvals and orders required as of the date
hereof to own its properties and conduct its business and to enter into this
Subscription Agreement and the other Offering Materials and to be bound by the
provisions and conditions hereof or therein.  The Company further
represents that the securities offered hereby are being offered pursuant to an
exemption from the registration requirements of the 1933 Act and applicable
state securities laws for nonpublic offerings.

       

      5.           The
undersigned agrees and acknowledges that the Company has the right to utilize
the services of a placement agent and if utilized, may receive a cash
commission, at a rate that is compatible with industry standards, from the
Common Stock sold by such placement agent.

       

      6.           The
undersigned does not at this time have rights to have the shares of Company’s
Common Stock issuable under the Offering Materials registered with the
Securities and Exchange Commission.

       

      7.           Except
as otherwise specifically provided for hereunder, no party shall be deemed to
have waived any of his, her, or its rights hereunder or under any other
agreement, instrument, or papers signed by any of them with respect to the
subject matter hereof unless such waiver is in writing and signed by the party
waiving said right.  Except as otherwise specifically provided for
hereunder, no delay or omission by any party in exercising any right with
respect to the subject matter hereof shall operate as a waiver of such right or
of any such other right.  A waiver on any one occasion with respect to
the subject matter hereof shall not be construed as a bar to, or waiver of, any
right or remedy on any future occasion.  All rights and remedies with
respect to the subject matter hereof, whether evidenced hereby or by any other
agreement, instrument, or paper, will be cumulative, and may be exercised
separately or concurrently.

       

      8.           The
parties have not made any representations or warranties with respect to the
subject matter hereof not set forth herein, and this Subscription Agreement,
together with any instruments executed simultaneously herewith, constitutes the
entire agreement between them with respect to the subject matter
hereof.  All understandings and agreements heretofore existing between
the parties with respect to the subject matter hereof are merged in this
Subscription Agreement and any such instrument, which alone fully and completely
express their agreement.

       

      
        
           

        

        
          8

          
            

          

        

        
           

        

      

       

      9.           This
Subscription Agreement may not be changed, modified, extended, terminated, or
discharged orally, but only by an agreement in writing, which is signed by all
of the parties to this Subscription Agreement.

       

      10.           The
parties agree to execute any and all such other and further instruments and
documents, and to take any and all such further actions reasonably required to
effectuate this Subscription Agreement and the intent and purposes
hereof.

       

      11.           If
any provision or any portion of any provision of this Subscription Agreement or
the application of any such provision or any portion thereof to any person or
circumstance, shall be held invalid or unenforceable, the remaining portion of
such provision and the remaining portion of such provision as is held invalid or
unenforceable to persons or circumstances other than those as to which it is
held invalid or unenforceable, shall not be affected thereby.

       

      12.           This
Subscription Agreement shall be governed by and construed in accordance with the
laws of the State of Nevada and the undersigned hereby consents to the
jurisdiction of the courts of the State of New York and/or the Shared States
District Court for the Southern District of New York.

       

      
        
           

        

        
          - 9
-

          
            

          

        

        
           

        

      

       

      ALL
SUBSCRIBERS MUST COMPLETE A COPY OF THIS PAGE

       

      __________________________

      (Print
Name of Subscriber)

       

      IN WITNESS WHEREOF, the
undersigned has executed this Subscription Agreement on this ____ day of
________, 2011.

       

      Common
Stock Subscription Amount $______

       

      
        	
                1.

              	
                 ̈

              	
                Individual

              
	 
      	 
      	 
      
	
                2.

              	
                 ̈

              	
                Joint
      Tenants with Right of Survivorship

              
	 
      	 
      	 
      
	
                3.

              	
                 ̈

              	
                Community
      Property

              
	
                 
      

              	 
      	 
      
	
                4.

              	
                 ̈

              	
                Tenants
      in Common

              
	 
      	 
      	 
      
	
                5.

              	
                 ̈

              	
                Corporation/Partnership

              
	
                 
      

              	 
      	 
      
	
                6.

              	
                 ̈

              	
                IRA
      of________________

              
	 
      	 
      	 
      
	
                7.

              	
                 ̈

              	
                Trust

              
	 
      	 
      	 
      
	 
      	 
      	
                Date
      Opened ___________

              
	 
      	 
      	 
      
	
                8.

              	
                 ̈

              	
                As
      A Custodian For________________

              
	 
      	 
      	 
      
	 
      	 
      	
                Under
      the Uniform Transfer to Minors Act of the

              
	 
      	 
      	 
      
	 
      	 
      	
                State
      of ___________

              
	 
      	 
      	 
      
	
                9.

              	
                 ̈

              	
                Married
      with Separate

              
	 
      	 
      	 
      
	 
      	 
      	
                Property

              
	 
      	 
      	 
      
	
                10.

              	
                 ̈

              	
                Keogh
      of ____________

              

      

       

      
        
           

        

        
          - 10
-

          
            

          

        

        
           

        

      

       

      EXECUTION
BY SUBSCRIBER WHO IS A NATURAL PERSON

       

      
        
          
            
              
                
                  
                    
                      	 
      
	
                              Exact
      Name in Which Title is to be Held

                            
	 
      
	 
      
	
                              Signature

                            
	 
      
	 
      
	
                              Name
      (Please Print)

                            
	 
      
	 
      
	
                              Title
      of Person Executing Agreement

                            
	 
      
	 
      
	
                              Address:  Number
      and Street

                            
	 
      
	 
      
	
                              City

                            	
                              State

                            	
                              Zip
      Code

                            
	 
      
	 
      
	
                              Social
      Security
Number

                            

                    

                  

                

              

            

          

        

      

       

      Accepted
this ___ day of _______, 2011, on behalf of
_______________________

       

      
        
          
            	
                    BIOPOWER
      OPERATIONS CORPORATION

                  
	 
      
	 
      	
                    By:

                  	 
      	 
      
	 
      	 
      	
                    Name:

                  
	 
      	 
      	
                    Title:

                  

          

        

      

       

      
        
           

        

        
          - 11
-

          
            

          

        

        
           

        

      

      EXECUTION
BY SUBSCRIBER WHICH IS A CORPORATION,

       

      PARTNER,
TRUST, ETC.

       

      
        
          
            
              
                
                  
                    
                      	 
      
	
                              Exact
      Name in Which Title is to be Held

                            
	 
      
	 
      
	
                              Signature)

                            
	 
      
	 
      
	
                              Name
      (Please Print)

                            
	 
      
	 
      
	
                              Title
      of Person Executing Agreement

                            
	 
      
	 
      
	
                              Address:  Number
      and Street

                            
	 
      
	 
      
	
                              City

                            	
                              State

                            	
                              Zip
      Code

                            
	 
      
	 
      
	
                              Tax
      Identification
Number

                            

                    

                  

                

              

            

          

        

      

       

      Accepted
this ___ day of _______, 2011, on behalf of _______________

       

      
        
          
            	
                    BIOPOWER
      OPERATIONS CORPORATION

                  
	 
      
	 
      	
                    By:

                  	 
      	 
      
	 
      	
                    Name:

                  	 
      
	 
      	
                    Title:

                  	 
      

          

        

      

       

      
        
           

        

        
          - 12
-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00184-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00184-of-00352.parquet"}]]